New IDT webinar to highlight benefits of using RNP complexes for efficient genome modifications

NewsGuard 100/100 Score

IDT demonstrates how ribonucleoprotein delivery overcomes challenges in CRISPR-mediated genome editing

Integrated DNA Technologies (IDT) will host an informative webinar entitled ‘Ribonucleoprotein delivery of CRISPR-Cas9 reagents for increased gene editing efficiency’ on December 14, 2016.

The webinar, by Dr Rolf Turk, Research Scientist, Molecular Genetics at IDT, will be held at two different times (9am and 1pm Central Standard Time) and will describe the advantages of using a Cas9:crRNA:tracrRNA ribonucleoprotein (RNP) complex for increased efficiency in genome editing.

The CRISPR/Cas9 system is now one of the most well-known tools for effective genome modifications, but there are still common issues with low editing efficiency or delivery problems in primary or difficult-to-transfect cells. This webinar will describe the benefits of using RNP complexes for efficient and effective delivery, including ease of use, limiting off-target effects, and stability.

Dr Rolf Turk, who has been working at IDT to optimize delivery protocols for CRISPR, will also present data showing how genome editing efficiency rates are improved by IDT’s Cas9 electroporation enhancer, and provide advice on how to optimize transfection using the Alt-R™ CRISPR-Cas9 System in combination with different electroporation methodologies.

With various CRISPR methodologies to choose from, the webinar aims to assist attendees in selecting the most effective methods and tools for success in their genome modifications.

To register please select the desired session below, or contact IDT via the website




Session 1 December 14

9:00 AM

3:00 PM

12:00 AM

Session 2 December 14

1:00 PM

7:00 PM

4:00 AM


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Genes and age reveal new insights into cognitive variability, study finds